Viral hemorrhagic (hem-uh-RAJ-ik) fevers are infectious diseases that can cause severe, life-threatening illness. They can damage the walls of tiny blood vessels, making them leaky. They can also interfere with the blood's ability to clot. Vaccinations exist for only a few types of viral hemorrhagic fevers.
This report contains market size and forecasts of Hemorrhagic Fever Vaccine in global, including the following market information:
Global Hemorrhagic Fever Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Hemorrhagic Fever Vaccine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Hemorrhagic Fever Vaccine companies in 2021 (%)
The global Hemorrhagic Fever Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Yellow Fever Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hemorrhagic Fever Vaccine include Sanofi Pasteur, Green Cross, Merk & Co. and IAVI, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hemorrhagic Fever Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hemorrhagic Fever Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hemorrhagic Fever Vaccine Market Segment Percentages, by Type, 2021 (%)
Yellow Fever Vaccine
Dengue Vaccine
Ebola Vaccine
Global Hemorrhagic Fever Vaccine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hemorrhagic Fever Vaccine Market Segment Percentages, by Application, 2021 (%)
Investigational Use
Commercial Use
Global Hemorrhagic Fever Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hemorrhagic Fever Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hemorrhagic Fever Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Hemorrhagic Fever Vaccine revenues share in global market, 2021 (%)
Key companies Hemorrhagic Fever Vaccine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Hemorrhagic Fever Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi Pasteur
Green Cross
Merk & Co.
IAVI